Inhibrx Biosciences (INBX) Earnings Date, Estimates & Call Transcripts $23.34 +0.38 (+1.66%) As of 09:43 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Inhibrx Biosciences Earnings Summary Inhibrx Biosciences issued Q4 2024 earnings on May 14, 2025, reporting an EPS of -$2.80, which missed analysts' consensus estimates of -$2.55 by $0.25. With a trailing EPS of $116.75 and a P/E Ratio of 0.20, Inhibrx Biosciences' earnings are expected to decrease next year, from $104.88 to ($12.08) per share. Upcoming Earnings DateAug. 12Before Market OpensEstimatedConsensus EPS (May. 14) -$2.55 Actual EPS (May. 14) -$2.80 Missed By -$0.25 Q4 2024 Earnings ResourcesQ4 2024 Earnings Report Annual Report (10-K)INBX Upcoming EarningsInhibrx Biosciences' Q2 2025 earnings is scheduled for Tuesday, August 12, 2025, with a conference call scheduled on Wednesday, August 13, 2025 at 4:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.Powered by Get Inhibrx Biosciences Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Inhibrx Biosciences and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataINBX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.INBX Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Inhibrx Biosciences Analyst EPS EstimatesCurrent Year EPS Consensus Estimate $104.88 EPSNext Year EPS Consensus Estimate ($12.08) EPS Inhibrx Biosciences Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/12/2025(Estimated)--------5/14/2025Q4 2024-$2.55-$2.80 -$0.25-$2.80--3/17/2025Q4 2024-$2.88-$3.09 -$0.21-$3.09-$0.10M8/13/2024Q2 2024-$3.60$125.48+$129.08$125.48-$0.10M2/28/2024Q4 2023-$1.07-$1.73 -$0.66-$1.73$0.10M$1.63M11/9/2023Q3 2023-$1.01-$1.10 -$0.09-$1.10-$0.12M8/7/2023Q2 2023-$1.02-$1.08 -$0.06-$1.08-$0.03M Inhibrx Biosciences Earnings - Frequently Asked Questions When is Inhibrx Biosciences' earnings date? Inhibrx Biosciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 12th, 2025 based off last year's report dates. Learn more on INBX's earnings history. Did Inhibrx Biosciences beat their earnings estimates last quarter? In the previous quarter, Inhibrx Biosciences (NASDAQ:INBX) missed the analysts' consensus estimate of ($2.55) by $0.25 with a reported earnings per share (EPS) of ($2.80). Learn more on analysts' earnings estimate vs. INBX's actual earnings. How much revenue does Inhibrx Biosciences generate each year? Inhibrx Biosciences (NASDAQ:INBX) has a recorded annual revenue of $200,000.00. How much profit does Inhibrx Biosciences generate each year? Inhibrx Biosciences (NASDAQ:INBX) has a recorded net income of $1.69 billion. INBX has generated $116.75 earnings per share over the last four quarters. What is Inhibrx Biosciences' price-to-earnings ratio? Inhibrx Biosciences (NASDAQ:INBX) has a trailing price-to-earnings ratio of 0.20 and a forward price-to-earnings ratio of 0.22. What is Inhibrx Biosciences' EPS forecast for next year? Inhibrx Biosciences' earnings are expected to decrease from $104.88 per share to ($12.08) per share in the next year. More Earnings Resources from MarketBeat Related Companies SION Earnings Results AVXL Earnings Results ORIC Earnings Results LENZ Earnings Results ZYME Earnings Results RCUS Earnings Results AVDL Earnings Results COGT Earnings Results OCS Earnings Results CMRX Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles 3 Analysts Set $600 Target Ahead of Microsoft EarningsTesla: 2 Plays Ahead of Next Week's Earnings ReportFastenal Surges After Earnings Beat, Tariff Risks Loom3 Catalysts Converge on Intel Ahead of a Critical Earnings ReportSmith & Wesson Stock Falls on Earnings Miss, Tariff WoesWhat to Expect From the Q2 Earnings Reporting CycleBroadcom Slides on Solid Earnings, AI Outlook Still Strong This page (NASDAQ:INBX) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCentral Banks Are Hoarding Gold – Should You?The AI boom isn’t just transforming technology—it’s redefining global power, increasing government debt, and u...Lear Capital | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredAll New Social Security Numbers coming July 23?To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Next Commodity Crisis Just Got a Name: SilverElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inhibrx Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Inhibrx Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free INBX Stock Alerts